Journal rankings · indicator year 2013
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2013
Rheumatology journal rankings 2013
56 ranked journals · Subfield in Medicine
Rheumatology has 56 ranked journals in 2013. The median OJR rose 0.08 on 2012 to 0.95, below the world average of 1.00; Q1 starts at OJR 1.79. The top three are Annals of the Rheumatic Diseases, Arthritis & Rheumatism, and Current Opinion in Rheumatology.
Ranks and citation indicators: 2013. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2010–2012, the window the 2013 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery675
- Pulmonary and Respiratory Medicine266
- Public Health, Environmental and Occupational Health227
- Cardiology and Cardiovascular Medicine218
- Oncology170
- Infectious Diseases162
- Epidemiology157
- Endocrinology, Diabetes and Metabolism132
- Neurology132
- Radiology, Nuclear Medicine and Imaging129
- Physiology120
- Psychiatry and Mental health119
- Rheumatology56
Show all 42 subfields
- Orthopedics and Sports Medicine88
- Dermatology73
- Pediatrics, Perinatology and Child Health73
- Ophthalmology70
- Hematology64
- Obstetrics and Gynecology55
- Nephrology46
- Pharmacology40
- Reproductive Medicine40
- Complementary and alternative medicine39
- Geriatrics and Gerontology36
- Emergency Medicine34
- Otorhinolaryngology33
- Rehabilitation24
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine22
- Hepatology18
- Genetics17
- Immunology and Allergy17
- Urology11
- Anesthesiology and Pain Medicine10
- Gastroenterology6
- Internal Medicine5
- Family Practice2
- Transplantation2
- Biochemistry1
- Health Informatics1
- Anatomy0
- Microbiology0
56 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2012. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2010–2012, the window the 2013 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2010–2012 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2004 to 2013. | Compare |
|---|---|---|---|---|---|---|---|
1Annals of the Rheumatic DiseasesBMJ · United Kingdom | 3.70Q1 | 8.38 1.06 down from 2012 | 1,339 | 12% | $4,870 | ||
2Arthritis & RheumatismWiley · United States | 3.47Q1 | 7.76 0.19 up from 2012 | 1,509 | 33% | — | ||
3Current Opinion in RheumatologyLippincott Williams & Wilkins · United States | 3.19Q1 | 6.53 0.38 down from 2012 | 303 | 22% | — | ||
4Best Practice & Research Clinical RheumatologyElsevier BV · Netherlands | 2.81Q1 | 4.78 1.00 down from 2012 | 197 | 10% | $4,180 | ||
5European Cells and MaterialsOASwitzerland | 2.77Q1 | 6.20 0.29 up from 2012 | 201 | 100% | $1,000 | ||
6Autoimmunity ReviewsElsevier BV · Netherlands | 2.74Q1 | 7.72 0.30 up from 2012 | 472 | 17% | $4,730 | ||
7Arthritis Care & ResearchWiley · United States | 2.69Q1 | 5.69 1.03 up from 2012 | 913 | 37% | $4,640 | ||
8Osteoarthritis and CartilageElsevier BV · United Kingdom | 2.17Q1 | 5.28 0.04 down from 2012 | 652 | 100% | $3,700 | ||
9Rheumatic Disease Clinics of North AmericaElsevier BV · United States | 1.99Q1 | 2.92 0.62 down from 2012 | 141 | 16% | $3,500 | ||
10Arthritis Research & TherapyOABioMed Central · United Kingdom | 1.98Q1 | 3.93 1.47 down from 2012 | 1,158 | 100% | $3,690 | ||
11Lara D. VeekenOxford University Press · United Kingdom | 1.89Q1 | 4.19 0.15 up from 2012 | 1,172 | 38% | $4,597 | ||
12International Journal of RheumatologyHindawi Publishing Corporation · United Kingdom | 1.85Q1 | 4.14 1.90 up from 2012 | 104 | 100% | $950 | ||
13Current Rheumatology ReportsSpringer Science+Business Media · United States | 1.81Q1 | 4.23 0.84 up from 2012 | 230 | 23% | $4,490 | ||
14Seminars in Arthritis and RheumatismElsevier BV · United States | 1.79Q1 | 5.06 0.78 up from 2012 | 206 | 13% | $4,370 | ||
15ArthritisHindawi Publishing Corporation · United Kingdom | 1.60Q2 | 3.47 1.13 up from 2012 | 59 | 100% | — | ||
16Autoimmune DiseasesOAHindawi Publishing Corporation · United Kingdom | 1.53Q2 | 3.66 1.14 up from 2012 | 104 | 100% | $950 | ||
17The Journal of RheumatologyThe Journal of Rheumatology Publishing Company Limited · Canada | 1.41Q2 | 3.17 0.05 down from 2012 | 1,370 | 97% | — | ||
18LupusSAGE Publishing · United Kingdom | 1.32Q2 | 3.03 0.19 down from 2012 | 697 | 13% | $4,150 | ||
19Expert Review of Clinical ImmunologyTaylor & Francis · United Kingdom | 1.27Q2 | 3.06 0.02 up from 2012 | 262 | 28% | — | ||
20Clinical Medicine Insights Arthritis and Musculoskeletal DisordersOASAGE Publishing · United Kingdom | 1.21Q2 | 2.48 0.05 up from 2012 | 32 | 100% | $4,150 | ||
21Therapeutic Advances in Musculoskeletal DiseaseOASAGE Publishing · United Kingdom | 1.20Q2 | 3.17 2.56 up from 2012 | 88 | 100% | $2,650 | ||
22Clinical RheumatologySpringer Science+Business Media · Belgium | 1.08Q2 | 2.39 0.09 down from 2012 | 792 | 17% | $4,890 | ||
23Joint Bone SpineElsevier BV · France | 1.06Q2 | 2.39 0.14 down from 2012 | 603 | 7% | $3,020 | ||
24The Open Rheumatology JournalOABentham Science Publishers · Netherlands | 1.05Q2 | 2.49 1.33 up from 2012 | 77 | 100% | — | ||
25Scandinavian Journal of RheumatologyTaylor & Francis · United Kingdom | 1.02Q2 | 2.30 0.02 up from 2012 | 321 | 9% | — | ||
26Connective Tissue ResearchTaylor & Francis · United Kingdom | 1.02Q2 | 2.18 0.07 down from 2012 | 182 | 25% | — | ||
27CartilageSAGE Publishing · United States | 0.96Q2 | 1.66 0.11 down from 2012 | 129 | 100% | $2,650 | ||
28International Journal of Rheumatic DiseasesWiley · Australia | 0.96Q2 | 1.81 0.04 up from 2012 | 293 | 34% | $3,700 | ||
29International Urogynecology JournalSpringer Science+Business Media · United Kingdom | 0.95Q3 | 2.03 0.64 down from 2012 | 888 | 30% | $3,790 | ||
30Nature Reviews RheumatologyNature Portfolio · United Kingdom | 0.86Q3 | 3.57 0.52 down from 2012 | 714 | 16% | — | ||
31Modern RheumatologyOxford University Press · United States | 0.84Q3 | 2.11 0.53 up from 2012 | 913 | 6% | $3,208 | ||
32Musculoskeletal CareWiley · United Kingdom | 0.82Q3 | 1.65 0.04 down from 2012 | 97 | 41% | $3,240 | ||
33ISRN RheumatologyOAHindawi Publishing Corporation · Egypt | 0.79Q3 | 1.59 1.17 up from 2012 | 32 | 100% | — | ||
34Rheumatology InternationalSpringer Science+Business Media · Germany | 0.76Q3 | 1.63 0.26 up from 2012 | 1,278 | 16% | $4,990 | ||
| 0.74Q3 | 2.50 0.53 down from 2012 | 77 | — | — | |||
36JCR Journal of Clinical RheumatologyLippincott Williams & Wilkins · United States | 0.70Q3 | 1.46 0.03 up from 2012 | 404 | 8% | — | ||
37Revista Brasileira de ReumatologiaOAElsevier BV · Brazil | 0.67Q3 | 1.36 0.28 up from 2012 | 218 | 100% | $2,490 | ||
38UrogynecologyLippincott Williams & Wilkins · United States | 0.60Q3 | 1.34 0.79 up from 2012 | 214 | 17% | — | ||
39Case Reports in RheumatologyOAHindawi Publishing Corporation · United Kingdom | 0.42Q3 | 0.81 0.81 up from 2012 | 48 | 100% | $790 | ||
40Reumatología ClínicaElsevier BV · Spain | 0.34Q3 | 0.85 0.40 up from 2012 | 291 | 7% | $3,180 | ||
41International Journal of Clinical RheumatologyOAOMICS Publishing Group · United Kingdom | 0.33Q3 | 0.68 0.03 up from 2012 | 201 | 15% | — | ||
42ReumatismoOAPAGEPress (Italy) · Italy | 0.29Q3 | 0.64 0.09 up from 2012 | 545 | 100% | — | ||
43Autoimmunity HighlightsOASpringer Science+Business Media · Italy | 0.28Q4 | 0.86 0.50 down from 2012 | 42 | 100% | $1,990 | ||
44Zeitschrift für RheumatologieSpringer Science+Business Media · Germany | 0.27Q4 | 0.67 0.15 down from 2012 | 299 | 11% | $3,390 | ||
45Reumatología Clínica (English Edition)Elsevier BV · Spain | 0.27Q4 | 0.62 0.28 up from 2012 | 278 | 0% | $3,170 | ||
46La Revue de Médecine InterneElsevier BV · France | 0.21Q4 | 0.64 0.13 down from 2012 | 789 | 1% | $2,300 | ||
47PteridinesOADe Gruyter Open · Germany | 0.21Q4 | 0.75 0.20 up from 2012 | 31 | 100% | $1,808 | ||
48Alexandria Journal of MedicineOAElsevier BV | 0.21Q4 | 0.45 0.27 up from 2012 | 140 | 100% | $750 | ||
49Rheumatology ReportsOAPAGEPress (Italy) · Italy | 0.20Q4 | 0.38 0.09 up from 2012 | 35 | 100% | — | ||
50Current Rheumatology ReviewsBentham Science Publishers · Netherlands | 0.19Q4 | 0.53 0.12 up from 2012 | 98 | 0% | — |
Subfields of Medicine, with Rheumatology highlighted.
- Surgery675
- Pulmonary and Respiratory Medicine266
- Public Health, Environmental and Occupational Health227
- Cardiology and Cardiovascular Medicine218
- Oncology170
- Infectious Diseases162
- Epidemiology157
- Endocrinology, Diabetes and Metabolism132
- Neurology132
- Radiology, Nuclear Medicine and Imaging129
- Physiology120
- Psychiatry and Mental health119
- Orthopedics and Sports Medicine88
- Dermatology73
- Pediatrics, Perinatology and Child Health73
- Ophthalmology70
- Hematology64
- Rheumatology56
- Obstetrics and Gynecology55
- Nephrology46
- Pharmacology40
- Reproductive Medicine40
- Complementary and alternative medicine39
- Geriatrics and Gerontology36
- Emergency Medicine34
- Otorhinolaryngology33
- Rehabilitation24
- Critical Care and Intensive Care Medicine22
- Pathology and Forensic Medicine22
- Hepatology18
- Genetics17
- Immunology and Allergy17
- Urology11
- Anesthesiology and Pain Medicine10
- Gastroenterology6
- Internal Medicine5
- Family Practice2
- Transplantation2
- Biochemistry1
- Health Informatics1
- Anatomy0
- Microbiology0
Journals
Citations made in 2013. Corpus-wide, 76.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
11 additional Rheumatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2010–2012, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2013. Publication window: 2010–2012. How these summaries are calculated
- Ranked journals
- 56
- Window papers (baseline)
- 49,400 +14.9% from indicator year 2010
- Median OJR
- 0.95 +19.6% from indicator year 2010
- Rising journals (2025)
- 6
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2010–2012 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 20 | 24 | 25 | 27 | 30 | 32 | 37 | 38 | 38 | 39 | 43 | 49 | 53 | 56 | 59 | 58 | 58 | 65 | 65 | 67 | 69 | 67 | 65 | 67 | 67 | 70 | |
| Window papers (baseline) | 17,821 | 20,685 | 22,377 | 24,459 | 25,269 | 27,867 | 30,643 | 33,672 | 36,348 | 39,439 | 42,988 | 46,086 | 48,179 | 49,400 | 51,214 | 53,341 | 54,578 | 55,366 | 56,123 | 57,306 | 59,410 | 62,541 | 65,720 | 67,501 | 67,701 | 69,555 | |
| Median OJR | 0.91 | 0.782 | 0.862 | 0.81 | 0.884 | 1.05 | 0.855 | 0.803 | 0.92 | 0.891 | 0.7969 | 0.888 | 0.877 | 0.95 | 0.879 | 0.847 | 0.9574 | 0.889 | 0.873 | 0.93 | 0.99 | 0.9569 | 0.869 | 0.851 | 0.785 | 0.7970 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.